Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 326

Gastro-Oesophageal Reflux Disease (GORD) in Children

NICE guideline [NG1] Gastro-oesophageal reflux disease in children and young people: diagnosis and management. Last updated: Oct 2019.

Background Information

Definition

GOR:

  • Passage of gastric content into the oesophagus
  • Common physiological event
  • Often asymptomatic and associated with overt regurgitation (visible regurgitation of feeds)

GORD:

  • GOR that causes symptoms (e.g. discomfort or pain)

Risk Factors

  • Premature birth
  • Obesity
  • Hiatus hernia
  • Congenital diaphragmatic hernia (repaired)
  • Congenital oesophageal atresia (repaired)
  • Neurodisability
  • Parental history of heartburn / acid regurgitation
  • Asthma (but not been shown to cause it or worsen it)

Clinical Features

Possible clinical features:

  • Heart burn / retrosternal pain / epigastric pain
  • Feeding difficulties (e.g. refusing to feed, gagging, choking, regurgitation)
  • Hoarseness
  • Cough
  • Faltering growth

 

Red Flags

Presence of the following red flags suggests disorders other than GOR:
 

Feature Possible implication
Frequent projectile vomiting Hypertrophic pyloric stenosis
Bile-stained vomit Intestinal obstruction
Abdominal distension / tenderness / palpable mass
Haematemesis Upper GI bleed
Blood in stool Lower GI bleed
Cows' milk protein allergy
Bacterial gastroenteritis
Chronic diarrhoea Cows' milk protein allergy
Late onset (>8 weeks) UTI

 

Complications

Possible complications:

  • Reflux oesophagitis
  • Aspiration pneumonia
  • Otitis media
  • Dental erosion

Diagnosis Guidelines

Investigation and Diagnosis

Clinical diagnosis is sufficient in most cases.

Investigations should not be performed routinely
 

Investigation Indications
Upper GI endoscopy + biopsy Specialist hospital assessment with possible endoscopy if:

  • Haematemesis
  • Melaena
  • Dysphagia
  • No improvement after 1 y/o
  • Persistent faltering growth
  • Symptoms requiring medical therapy / refractory to medical therapy
  • Unexplained iron deficiency anaemia
Upper GI contrast study To exclude anatomical abnormalities

Consider if:

  • Billious vomiting
  • Dysphagia
Oesophageal pH study Gold standard test to confirm GOR

Consider if there are unexplained complications of GOR:

  • Recurrent aspiration pneumonia
  • Unexplained apnoeas
  • Unexplained non-epileptic seizure-like events
  • Unexplained upper airway inflammation
  • Dental erosion associated with neurodisability
  • Frequent otitis media

 

Investigation for UTI should be considered if there is late onset GOR (>8 weeks old) + faltering growth + frequent regurgitation and marked distress.

UTI typically present non-specifically in young patients, vomiting or reflux-like symptoms may reflect systemic illness like UTI rather than primary GOR.

Management Guidelines

Patient / Carer Education

Advise that:

  • Very common (affects at least 40% of infants)
  • Episodes may be frequent (5% of those affected have 6 or more episodes each day)
  • Usually becomes less frequent with time (resolves in 90% of affected infants before 1 y/o)
  • Does not usually need further investigation or treatment

General / Conservative Management

Always attempt general / conservative management first, and only proceed to pharmacological management if these fail.
 

Breast-Fed Infants

Carry out a breastfeeding assessment and advice

Formula-Fed Infants

Review feeding history:

  • Reduce feed volumes only if excessive for infant's weight
  • Trial of smaller but more frequent feeds (while maintaining an appropriate total daily amount of milk)
  • If the above failed, offer a trial of thickened formula (e.g. containing rice starch, cornstarch, locust bean gum, carob bean gum)

Pharmacological Management

1st line: alginate therapy (trial of 1-2 weeks)

Do not offer PPI or H2 receptor antagonist to treat isolated regurgitation

Consider 4-week trial of PPI or H2 receptor antagonist if:

  • Unable to communicate about their symptoms (e.g. very young, communication difficulties) with feeding difficulties / faltering growth / distressed behaviour
  • Persistent heartburn / retrosternal / epigastric pain
  • Endoscopy-proven reflux oesophagitis

Further Management

Further management options include:

  • Enteral feeding (esp. in faltering growth)
  • Surgery – fundoplication (last resort)
    • Offer upper GI endoscopy and consider other investigations before considering fundoplication

References

Original Guideline

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD